Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.53 AUD | +3.12% |
|
-10.64% | -2.94% |
Jul. 08 | Morgans Financial Downgrades Clinuvel Pharmaceuticals to Hold From Add; Price Target is AU$16 | MT |
Jun. 28 | Clinuvel Pharmaceuticals Limited Announces Change of Company Secretary | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.94% | 501M | |
+6.57% | 97.06B | |
+7.24% | 41.54B | |
-8.49% | 33.89B | |
+83.27% | 29.78B | |
-12.97% | 15.63B | |
-0.80% | 13.66B | |
-12.22% | 11.43B | |
+173.60% | 10.37B | |
+4.64% | 9.14B |
- Stock Market
- Equities
- CUV Stock
- News Clinuvel Pharmaceuticals Limited
- Clinuvel Pharmaceuticals Secures Orphan Drug Designation in Europe for Metabolic Disorder Drug